Dec 15, 2018 | Published Research
This study published in the World Journal of Diabetes evaluates the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records.Manfred Paul Stapff, CMO, TriNetX Inc.,...
Nov 12, 2018 | Events, Published Research
This scientific poster investigates the risk of Parkinson’s Disease (PD) in patients taking adrenergic drug treatments. Download the poster...
Nov 12, 2018 | Events, Published Research
This scientific poster is comparing the risk of suicidality in adult versus youth patients treated with serotonin reuptake inhibitors—A real-world evidence-based approach. Download the poster...
Nov 12, 2018 | Events, Published Research
This scientific poster investigates the risk of stroke or systemic embolism in chronic kidney disease patients with atrial fibrillation. Download the poster...
Nov 12, 2018 | Events, Published Research
This scientific poster explores real-world evidence of metastatic breast cancer treatment: a comparison of adverse effects between palbociclib treatment and endocrine therapy. Download the poster...
Nov 12, 2018 | Events, Published Research
This scientific poster introduces a quality assurance method and visualization that evaluates the accuracy of NLP fact extraction from anatomic pathology reports. Download the poster...
Nov 12, 2018 | Press Releases
Barcelona, Spain – ISPOR Europe – November 12, 2018 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence, today announced new functionality that simplifies the way...
Nov 12, 2018 | Press Releases
Harmonized and Integrated with Highly Intuitive Analytics for Use in Designing Protocols and Conducting Observational Research Barcelona, Spain – ISPOR Europe – November 12, 2018 — TriNetX, the global health research network that revolutionizes clinical research and...
Oct 10, 2018 | Press Releases
Cambridge, MA, October 10, 2018 — Allergan, a leading global pharmaceutical company, has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort...
Sep 25, 2018 | Press Releases
Global Network of Researchers Arrive in Boston to Collaborate and Discuss R&D at TriNetX Summit Cambridge, MA, September 25, 2018 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the creation of...
